{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:31:32Z","timestamp":1776202292653,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.it.2013.05.001","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T20:47:17Z","timestamp":1371156437000},"page":"453-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Glycolipid antigens and autoantibodies in autoimmune neuropathies"],"prefix":"10.1016","volume":"34","author":[{"given":"Hugh J.","family":"Willison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl S.","family":"Goodyear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2013.05.001_bib0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1399-0039.2006.00721.x","article-title":"ABO blood group and related antigens, natural antibodies and transplantation","volume":"68","author":"Milland","year":"2006","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.it.2013.05.001_bib0010","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.bbagen.2012.02.005","article-title":"Repertoire of human natural anti-glycan immunoglobulins. Do we have auto-antibodies?","volume":"1820","author":"Bovin","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.it.2013.05.001_bib0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ajh.10062","article-title":"Autoimmune hemolytic anemia","volume":"69","author":"Gehrs","year":"2002","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.it.2013.05.001_bib0020","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/WCO.0b013e328357a77f","article-title":"Autoantibodies in immune-mediated neuropathies","volume":"25","author":"Chavada","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.it.2013.05.001_bib0025","doi-asserted-by":"crossref","first-page":"25859","DOI":"10.1074\/jbc.R200001200","article-title":"Combinatorial ganglioside biosynthesis","volume":"277","author":"Kolter","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2013.05.001_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jss.400080102","article-title":"Ganglioside structures and distribution: are they localized at the nerve ending?","volume":"8","author":"Ledeen","year":"1978","journal-title":"J. Supramol. Struct."},{"key":"10.1016\/j.it.2013.05.001_bib0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0076-6879(82)83012-7","article-title":"Gangliosides: structure, isolation, and analysis","volume":"83","author":"Ledeen","year":"1982","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.it.2013.05.001_bib0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.1998.tb09669.x","article-title":"The role of GM1 and other gangliosides in neuronal differentiation. Overview and new finding","volume":"845","author":"Ledeen","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.it.2013.05.001_bib0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.autrev.2011.05.011","article-title":"Autoimmune diseases of the peripheral nervous system","volume":"11","author":"Kieseier","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.it.2013.05.001_bib0050","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.it.2013.05.001_bib0055","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2013.05.001_bib0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12016-010-8213-3","article-title":"Guillain\u2013Barr\u00e9 syndrome \u2013 a classical autoimmune disease triggered by infection or vaccination","volume":"42","author":"Israeli","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.it.2013.05.001_bib0065","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.it.2013.05.001_bib0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/WCO.0b013e32830b84b7","article-title":"Ganglioside antibodies and neuropathies","volume":"21","author":"Rinaldi","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.it.2013.05.001_bib0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/mus.880180407","article-title":"Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection","volume":"18","author":"Kusunoki","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.it.2013.05.001_bib0080","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrmicro1718","article-title":"Campylobacter jejuni: molecular biology and pathogenesis","volume":"5","author":"Young","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2013.05.001_bib0085","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI59110","article-title":"Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy","volume":"122","author":"Fewou","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2013.05.001_bib0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1749-6632.1978.tb22017.x","article-title":"Immunogenicity of liposomal model membranes","volume":"308","author":"Kinsky","year":"1978","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.it.2013.05.001_bib0095","first-page":"4948","article-title":"Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells","volume":"52","author":"Lloyd","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.it.2013.05.001_bib0100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ana.20222","article-title":"Ganglioside complexes as new target antigens in Guillain\u2013Barr\u00e9 syndrome","volume":"56","author":"Kaida","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.it.2013.05.001_bib0105","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jneuroim.2006.09.013","article-title":"Anti-ganglioside complex antibodies associated with severe disability in GBS","volume":"182","author":"Kaida","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.it.2013.05.001_bib0110","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/01.wnl.0000335160.72184.7d","article-title":"GM1\/GalNAc-GD1a complex: a target for pure motor Guillain\u2013Barre syndrome","volume":"71","author":"Kaida","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.it.2013.05.001_bib0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jneuroim.2010.02.001","article-title":"Antibodies to gangliosides and ganglioside complexes in Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: mini-review","volume":"223","author":"Kaida","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.it.2013.05.001_bib0120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI37338","article-title":"The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice","volume":"119","author":"Greenshields","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2013.05.001_bib0125","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-1-61779-373-8_28","article-title":"Combinatorial glycoarray","volume":"808","author":"Rinaldi","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.it.2013.05.001_bib0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1084\/jem.20101499","article-title":"Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70\u2013","volume":"208","author":"Griffin","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2013.05.001_bib0135","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.4049\/jimmunol.0900432","article-title":"Phosphoinositide 3-kinase p110\u03b4 regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses","volume":"183","author":"Durand","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2013.05.001_bib0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21307\/immunohematology-2019-231","article-title":"The ABO blood group system revisited: a review and update","volume":"25","author":"Storry","year":"2009","journal-title":"Immunohematology"},{"key":"10.1016\/j.it.2013.05.001_bib0145","first-page":"10A","article-title":"ABO typing discrepancies in children requiring long-term nutritional support: it is the gut after all!","volume":"47","author":"Cooling","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.it.2013.05.001_bib0150","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.TP.0000142673.32394.95","article-title":"Immune response, accommodation, and tolerance to transplantation carbohydrate antigens","volume":"78","author":"Galili","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.it.2013.05.001_bib0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The Guillain\u2013Barr\u00e9 syndrome: a true case of molecular mimicry","volume":"25","author":"Ang","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.it.2013.05.001_bib0160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.wco.0000245367.36576.e9","article-title":"Bacterial infections in Guillain\u2013Barr\u00e9 and Fisher syndromes","volume":"19","author":"Yuki","year":"2006","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.it.2013.05.001_bib0165","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CDLI.8.2.314-319.2001","article-title":"Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients","volume":"8","author":"Strid","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.it.2013.05.001_bib0170","doi-asserted-by":"crossref","first-page":"e20953","DOI":"10.1371\/journal.pone.0020953","article-title":"Novel murine infection models provide deep insights into the \u201cm\u00e9nage \u00e0 trois\u201d of Campylobacter jejuni, microbiota and host innate immunity","volume":"6","author":"Bereswill","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.it.2013.05.001_bib0175","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1128\/IAI.00321-08","article-title":"The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion","volume":"76","author":"Louwen","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.it.2013.05.001_bib0180","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.51","article-title":"TH1 and TH2 response to Campylobacter jejuni antigen in Guillain\u2013Barre syndrome","volume":"68","author":"Nyati","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.it.2013.05.001_bib0185","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1128\/IAI.70.9.5008-5018.2002","article-title":"Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain\u2013Barr\u00e9 syndrome","volume":"70","author":"Bowes","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.it.2013.05.001_bib0190","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1172\/JCI6837","article-title":"Monoclonal antibodies raised against Guillain\u2013Barr\u00e9 syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations","volume":"104","author":"Goodyear","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2013.05.001_bib0195","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain\u2013Barre syndrome","volume":"101","author":"Yuki","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2013.05.001_bib0200","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jneuroim.2004.01.003","article-title":"Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain\u2013Barr\u00e9 patients","volume":"150","author":"Geleijns","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.it.2013.05.001_bib0205","doi-asserted-by":"crossref","first-page":"748","DOI":"10.4049\/jimmunol.0903014","article-title":"TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation","volume":"185","author":"Kuijf","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2013.05.001_bib0210","doi-asserted-by":"crossref","first-page":"e34416","DOI":"10.1371\/journal.pone.0034416","article-title":"Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice","volume":"7","author":"Huizinga","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.it.2013.05.001_bib0215","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/intimm\/14.4.411","article-title":"IFN-alpha\/beta enhances BCR-dependent B cell responses","volume":"14","author":"Braun","year":"2002","journal-title":"Int. Immunol."},{"key":"10.1016\/j.it.2013.05.001_bib0220","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.4049\/jimmunol.1200776","article-title":"Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni","volume":"189","author":"Klaas","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2013.05.001_bib0225","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0165-5728(94)90042-6","article-title":"Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome","volume":"50","author":"Willison","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.it.2013.05.001_bib0230","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/01.WNL.0000148727.02732.01","article-title":"HLA class II alleles are not a general susceptibility factor in Guillain\u2013Barr\u00e9 syndrome","volume":"64","author":"Geleijns","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.it.2013.05.001_bib0235","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/icb.2010.166","article-title":"Antibody responses to glycolipid-borne carbohydrates require CD4+ T cells but not CD1 or NKT cells","volume":"89","author":"Christiansen","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.it.2013.05.001_bib0240","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2004.05.001","article-title":"Polysaccharide processing and presentation by the MHCII pathway","volume":"117","author":"Cobb","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.it.2013.05.001_bib0245","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.it.2011.02.005","article-title":"Mucosal-associated invariant T cells: unconventional development and function","volume":"32","author":"Le Bourhis","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.it.2013.05.001_bib0250","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jneuroim.2009.10.010","article-title":"BAFF aids generation of IgG anti-ganglioside antibodies in response to Campylobacter jejuni lipo-oligosaccharide","volume":"218","author":"Matsumoto","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.it.2013.05.001_bib0255","doi-asserted-by":"crossref","DOI":"10.1038\/ni.2194","article-title":"B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen","author":"Puga","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2013.05.001_bib0260","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2007.05.014","article-title":"Origin of ganglioside complex antibodies in Guillain\u2013Barr\u00e9 syndrome","volume":"188","author":"Kuijf","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.it.2013.05.001_bib0265","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/glycob\/cwr139","article-title":"Anti-GM1\/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a","volume":"22","author":"Mauri","year":"2012","journal-title":"Glycobiology"},{"key":"10.1016\/j.it.2013.05.001_bib0270","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0014-5793(02)03479-8","article-title":"Glycosphingolipid-dependent cross-talk between glycosynapses interfacing tumor cells with their host cells: essential basis to define tumor malignancy","volume":"531","author":"Hakomori","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.it.2013.05.001_bib0275","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1073\/pnas.91.16.7390","article-title":"Selectin ligands","volume":"91","author":"Varki","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2013.05.001_bib0280","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.48.4.1104","article-title":"Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone","volume":"48","author":"Pestronk","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.it.2013.05.001_bib0285","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF00314652","article-title":"Acute motor neuropathy with antibodies to GM1 ganglioside","volume":"238","author":"Gregson","year":"1991","journal-title":"J. Neurol."},{"key":"10.1016\/j.it.2013.05.001_bib0290","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/glycob\/cwm095","article-title":"Sulfatide binding properties of murine and human antiganglioside antibodies","volume":"17","author":"Townson","year":"2007","journal-title":"Glycobiology"},{"key":"10.1016\/j.it.2013.05.001_bib0295","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1759-1961.2011.00022.x","article-title":"Neuropathophysiological potential of Guillain\u2013Barr\u00e9 syndrome anti-ganglioside-complex antibodies at mouse motor nerve terminals","volume":"2","author":"Zitman","year":"2011","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.it.2013.05.001_bib0300","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1468-1331.2012.03767.x","article-title":"Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy","volume":"20","author":"Galban-Horcajo","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.it.2013.05.001_bib0305","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1021\/ar700153u","article-title":"Two and three-dimensional pattern recognition of organized surfaces by specific antibodies","volume":"41","author":"Addadi","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.it.2013.05.001_bib0310","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/cbic.200700482","article-title":"Antibody labeling of cholesterol\/ceramide ordered domains in cell membranes","volume":"8","author":"Scheffer","year":"2007","journal-title":"Chembiochem"},{"key":"10.1016\/j.it.2013.05.001_bib0315","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/08820139509066860","article-title":"Specificity and cross-reactivity of anti-galactocerebroside antibodies","volume":"24","author":"McAlarney","year":"1995","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.it.2013.05.001_bib0320","series-title":"Presented at the J Neurol Neurosurg Psychiatry: Association of British Neurologists Annual Meeting","article-title":"Combinatorial glycoarray detects diverse new antibody specificities in Guillain\u2013Barre syndrome","author":"Rinaldi","year":"2012"}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490613000707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490613000707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T02:24:56Z","timestamp":1645755896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490613000707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1471490613000707"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2013.05.001","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycolipid antigens and autoantibodies in autoimmune neuropathies","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2013.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}